TIDI Products LLC, a manufacturer of single-use infection prevention products for medical and dental markets, has added three new gloves to its Novation LLC contract. The gloves include the 18 mil P2® HiRisk Latex Exam Gloves, 15 mil P2® SafetyPlus Latex Exam Gloves, and the 8 mil P2® Nitrile Exam Gloves.
The three gloves are use in high risk applications such as sterile processing/decontamination and chemotherapy drug compounding and administration. The 18 mil and 8 mil gloves are chemotherapy tested per the ASTM Standard D6978-05.
The existing contract, which began Nov. 1, 2010, runs through Oct. 31, 20111. The glove addition to the contract will complete Novations current offer to members for nitrile, vinyl and latex gloves.
Long COVID: Urgent Findings, Including Brain Alterations, Call for Renewed Public Health Focus
October 21st 2024New research highlights long COVID’s global impact, cognitive decline, and societal consequences, urging renewed focus on prevention, including vaccination, mask use, and better air quality.
Strengthening Defenses: Integrating Infection Control With Antimicrobial Stewardship
October 11th 2024Use this handout to explain the basics of why infection prevention and control and antimicrobial stewardship are essential and how the 2 fields must have a unified approach to patient and staff safety
NP and PA-Led Practices: A Possible Remedy for Health Care Worker Burnout
October 8th 2024Nurse practitioner (NP) and Physician Assistant (PA)-led practices offer autonomy, flexible schedules, and smaller patient loads, which could help mitigate burnout while reducing pressure on traditional healthcare systems and improving infection prevention.
Barrier Against Infection: Importance and Challenges of Isolation Room Cleaning in Hospitals
October 4th 2024Isolation rooms are essential for infection control in health care, relying on specialized design, advanced cleaning protocols, and technology to prevent cross-contamination and safeguard patient safety.